Stocks trim gains and commodities rebound to end a volatile week. Catch the Final Round at 4 p.m. ET for a breakdown of all the market action with Yahoo Finance's Nicole Sinclair, Rick Newman, Jen Rogers, and Bloomberg's Mike Regan.
Inversion deals targeted
Mega deals were called off this week, with the big news being the Allergan/Pfizer deal crumbling following new anti-inversion rules. Is this the end of the so-called inversions as we know them?
Jamie Dimon says the consumer—and big banks—are in fine shape. Should you listen? Rick Newman and Mike Regan decipher Dimon's big talk.
Winners and losers
Stocks finishing the week on a down note include Gap as March comparable sales dropped 6%; Ruby Tuesday getting 86ed on a profit and revenue miss; and Viacom—while the drama continues in the courtroom, shares were slapped with an underperform rating by RBC as it initiated coverage on the media sector.
Stocks on the move higher today include specialty drug company DepoMed on news activist Starboard Value has taken a stake, Alliance Fiber Optics on news it will be acquired by Corning, and Ulta Salon—the beauty products company shining today as it will replace Tenet Healthcare in the S&P 500.
- We'll get more Fed-speak throughout the week from the likes of John Williams, Jeffrey Lacker, Dennis Lockhart, and several others
- On Thursday, we'll get a reading on inflation in the country with CPI data for March. Last month we saw a year-over-year change of 2.3%
- On Friday, we'll get Industrial production figures for March as well. In February, we actually saw a dip in production of 0.5% month over month.